Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2664 (LINC02664)

Target
LINC02664
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2664 (LINC02664) is a member of the long intergenic non-coding RNA (lincRNA) family, a large class of RNAs longer than 200 nucleotides that do not overlap protein-coding genes and generally are not translated into protein[1][5]. LincRNAs, including LINC02664, are transcribed by RNA Polymerase II, sometimes with mRNA-like processing, though generally less efficiently. LincRNAs can have important biological roles, including the regulation of neighboring genes, chromatin modification, transcription regulation, and fine-tuning of gene expression within specific tissues or developmental stages[1][3][5]. While many lincRNAs have as yet uncharacterized or context-dependent functions, specific variants of LINC02664 have been identified as potential genetic markers for predisposition to certain diseases, including cancer[2]. There are currently no known drug interactions or mechanisms of action involving LINC02664, and it is not established as a direct therapeutic target.

Other names
LINC02664LOC105376481
02

Biological functions

Gene expression regulationChromatin remodelingTranscriptional regulationRNA stabilizationOther
03

Disease associations

CancerOther
04

Biomarkers

Potentially acts as a genetic marker of predisposition for disease[2]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2664 (LINC02664).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2664 (LINC02664).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call